Valneva SE (VALN) Tax Provisions (2021 - 2026)
Valneva SE (VALN) reported Tax Provisions of $936596.5 for Q1 2026, down 40.64% on a YoY basis from $1.6 million in Q1 2025, and up 180.46% sequentially from -$1.2 million in Q4 2025.
Valneva SE (VALN) Tax Provisions (2021 - 2026) Analysis & Trends
Valneva SE (VALN) has 6 years of Tax Provisions data on file, last reported at $936596.5 in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions fell 40.64% year-over-year to $936596.5; the trailing twelve-month figure through Mar 2026 stood at $481405.1 (down 79.26% YoY), and the FY2025 full-year result was $1.3 million, up 47.88% from the prior year.
- Tax Provisions improved to $936596.5 in Q1 2026, from -$1.2 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $2.2 billion in Q3 2022 to a low of -$2.2 billion in Q4 2022.
- A 5-year average of -$1.3 million and a median of $413954.9 in 2023 frame the typical range for Tax Provisions.
- Peak annual rise in Tax Provisions reached 188799.55% in 2022, while the deepest fall reached 38003.7% in 2022.
- Tracing VALN's Tax Provisions over 5 years: stood at -$2.2 billion in 2022, then surged by 100.19% to $4.2 million in 2023, then increased by 19.69% to $5.0 million in 2024, then sank by 123.18% to -$1.2 million in 2025, then jumped by 180.46% to $936596.5 in 2026.
- Business Quant data shows VALN's Tax Provisions at $936596.5 in Q1 2026, -$1.2 million in Q4 2025, and $935244.1 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Valneva SE | 811.46 Mn | 688.23 Mn | 5.08 Mn | 936,596.52 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 936,596.52 |
| Dec 31, 2025 | -1.16 Mn |
| Sep 30, 2025 | 935,244.07 |
| Jun 30, 2025 | -226,391.94 |
| Mar 31, 2025 | 1.58 Mn |
| Dec 31, 2024 | 5.02 Mn |
| Sep 30, 2024 | -4.06 Mn |
| Jun 30, 2024 | -215,377.52 |
| Dec 31, 2023 | 4.20 Mn |
| Sep 30, 2023 | 2.92 Mn |
| Jun 30, 2023 | -4.01 Mn |
| Mar 31, 2023 | -107,334.18 |
| Dec 31, 2022 | -2.21 Bn |
| Sep 30, 2022 | 2.18 Bn |
| Jun 30, 2022 | 2.99 Mn |
| Mar 31, 2022 | -563,413.53 |
| Dec 31, 2021 | 5.83 Mn |
| Sep 30, 2021 | -1.15 Mn |
| Jun 30, 2021 | -1.25 Mn |
| Mar 31, 2021 | 443,894.89 |